Cancer is a polygenic disorder that involves mutations in both tumor suppressor genes and oncogenes. However, a large body of preclinical data suggests that cancer growth can be halted or reversed by treatment with gene transfer vectors carrying a single growth-inhibitory or pro-apoptotic gene or a gene that can recruit anti-tumor immune responses.



